Logo image of HASH.CA

SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) Stock Fundamental Analysis

Canada - TSX-V:HASH - CA82888A1021 - Common Stock

0.205 CAD
-0.01 (-4.65%)
Last: 11/11/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HASH. HASH was compared to 31 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HASH have multiple concerns. HASH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year HASH was profitable.
In the past year HASH has reported a negative cash flow from operations.
HASH.CA Yearly Net Income VS EBIT VS OCF VS FCFHASH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

HASH's Return On Assets of 8.07% is amongst the best of the industry. HASH outperforms 90.32% of its industry peers.
HASH's Return On Equity of 15.32% is amongst the best of the industry. HASH outperforms 90.32% of its industry peers.
Industry RankSector Rank
ROA 8.07%
ROE 15.32%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HASH.CA Yearly ROA, ROE, ROICHASH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

With an excellent Profit Margin value of 16.68%, HASH belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
HASH has a worse Gross Margin (26.91%) than 70.97% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 16.68%
GM 26.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HASH.CA Yearly Profit, Operating, Gross MarginsHASH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

HASH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HASH has been increased compared to 1 year ago.
HASH has a worse debt/assets ratio than last year.
HASH.CA Yearly Shares OutstandingHASH.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
HASH.CA Yearly Total Debt VS Total AssetsHASH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.40, we must say that HASH is in the distress zone and has some risk of bankruptcy.
HASH has a better Altman-Z score (1.40) than 77.42% of its industry peers.
HASH has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
HASH has a Debt to Equity ratio (0.38) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACCN/A
WACC7.81%
HASH.CA Yearly LT Debt VS Equity VS FCFHASH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.62 indicates that HASH has no problem at all paying its short term obligations.
The Current ratio of HASH (2.62) is better than 74.19% of its industry peers.
A Quick Ratio of 0.94 indicates that HASH may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, HASH is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.62
Quick Ratio 0.94
HASH.CA Yearly Current Assets VS Current LiabilitesHASH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

HASH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -410.40%.
HASH shows a strong growth in Revenue. In the last year, the Revenue has grown by 120.93%.
EPS 1Y (TTM)-410.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.52%
Revenue 1Y (TTM)120.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%110.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HASH.CA Yearly Revenue VS EstimatesHASH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.83, the valuation of HASH can be described as very cheap.
HASH's Price/Earnings ratio is rather cheap when compared to the industry. HASH is cheaper than 93.55% of the companies in the same industry.
HASH is valuated cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.83
Fwd PE N/A
HASH.CA Price Earnings VS Forward Price EarningsHASH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HASH.CA Per share dataHASH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HASH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIMPLY SOLVENTLESS CONCENTRA

TSX-V:HASH (11/11/2025, 7:00:00 PM)

0.205

-0.01 (-4.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-19 2025-11-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.37%
Ins Owner ChangeN/A
Market Cap23.68M
Revenue(TTM)29.31M
Net Income(TTM)4.89M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.83
Fwd PE N/A
P/S 0.81
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)0.03
EY14.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.25
BVpS0.28
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.43
Profitability
Industry RankSector Rank
ROA 8.07%
ROE 15.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 16.68%
GM 26.91%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.95%
Cap/Sales 0.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.62
Quick Ratio 0.94
Altman-Z 1.4
F-Score4
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-410.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)120.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%110.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-302.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1009.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1332.95%
OCF growth 3YN/A
OCF growth 5YN/A

SIMPLY SOLVENTLESS CONCENTRA / HASH.CA FAQ

What is the fundamental rating for HASH stock?

ChartMill assigns a fundamental rating of 2 / 10 to HASH.CA.


Can you provide the valuation status for SIMPLY SOLVENTLESS CONCENTRA?

ChartMill assigns a valuation rating of 2 / 10 to SIMPLY SOLVENTLESS CONCENTRA (HASH.CA). This can be considered as Overvalued.


How profitable is SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) stock?

SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) has a profitability rating of 3 / 10.


What is the financial health of SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) stock?

The financial health rating of SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) is 3 / 10.